Frontlight ResearchEarly access
CompletedPhase 2
Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis
Key facts
- Who runs it
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Where
- Bangladesh1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 66 people enrolled
- Started
- 28 Jun 2025
- Ended
- 19 Nov 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- L-carnitine
- Placebo
- Record updated
- 6 February 2026
Who can take part
- Age
- 40 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Knee pain
- Radiographic evidence of mild to moderate knee osteoarthritis (Kellgren-Lawrence Grade: II-III)
- Above 40 years
- Both male and female
Who cannot take part
- Any history of intra-articular corticosteroid injections during the previous 2 months
- Chronic kidney disease or chronic liver disease
- Diagnosed with systemic inflammatory disorders, such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, gout
- A history of knee surgery or trauma
- Any antioxidant vitamins use, such as A, C, and E, or history of use in the last two months
- History of taking L-carnitine and NSAIDs in last 2 months
- Patients on immunosuppressant treatment
- Pregnancy or lactation
- Participation in another clinical trial
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the effects of L-carnitine on symptomatic improvement, oxidative stress, and inflammation in mild to moderate knee osteoarthritis patients.
The 2 groups in the trial
- Group A (Intervention group)Treatment being tested
Treatment: L-carnitine
- Group B (Placebo group)Placebo, for comparison
Treatment: Placebo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
- Record updated
- 6 February 2026